Performance analysis of Pacific Biosciences of California (PACB)
Annual Return
Over the past 3 years, PACB has had an average annual return of -51.14%, underperforming the benchmark SPY, which returned +22.77% annual.
Over the past 5 years, PACB has had an average annual return of -42.67%, underperforming the benchmark SPY, which returned +14% annual.
Over the past 10 years, PACB has had an average annual return of -16.35%, underperforming the benchmark SPY, which returned +15.53% annual.
Since Oct 27, 2010, PACB has had an average annual return of -13.94%, underperforming the benchmark SPY, which returned +14.66% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -15.48% | +2.16% | -81.35% | +19.92% | -60.02% | -21.13% | +404.61% | -30.53% | +180.26% | -30.51% | -71.07% | +67.48% |
| 2014 | 2013 | 2012 | 2011 | 2010 | |||||||
| +49.92% | +207.64% | -39.28% | -82.40% | -3.22% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +20.93% | -25.67% | -21.43% | +20.42% | -6.31% | +6.07% | -15.48% | ||||||
| 2025 | -15.81% | -5.87% | -18.59% | -5.99% | -13.19% | +28.67% | +11.27% | -5.01% | -2.26% | +82.67% | -0.84% | -19.42% | +2.16% |
| 2024 | -33.63% | -15.05% | -32.19% | -55.98% | +8.47% | -23.51% | +50.42% | -33.52% | +24.13% | +27.66% | -11.97% | -4.22% | -81.35% |
| 2023 | +35.57% | -18.13% | +27.54% | -8.46% | +16.78% | +7.44% | -0.68% | -14.61% | -25.97% | -25.99% | +37.22% | +15.68% | +19.92% |
| 2022 | -45.36% | +6.63% | -23.67% | -30.33% | -11.18% | -21.49% | -1.15% | +34.09% | -0.93% | +45.40% | +27.37% | -23.90% | -60.02% |
| 2021 | +24.71% | -5.50% | +8.96% | -10.39% | -9.38% | +29.28% | -8.06% | -2.61% | -18.40% | +3.64% | -12.35% | -11.85% | -21.13% |
| 2020 | -9.15% | -27.21% | -10.01% | +8.01% | +6.52% | -1.96% | +8.10% | +76.95% | +49.54% | +32.81% | +20.60% | +64.07% | +404.61% |
| 2019 | -6.49% | +5.63% | -1.08% | +2.21% | -9.34% | -9.69% | -10.73% | +2.77% | -7.02% | -6.21% | +6.22% | -0% | -30.53% |
| 2018 | +7.53% | -16.16% | -13.88% | +25.82% | -1.91% | +40.29% | +7.04% | +31.33% | +8.43% | -17.75% | +75.73% | -5.38% | +180.26% |
| 2017 | +26.87% | +4.77% | +2.38% | -23.78% | -16.27% | +7.87% | -8.41% | +51.84% | +6.04% | -19.42% | -24.60% | -17.22% | -30.51% |
Drawdown analysis of Pacific Biosciences of California (PACB)
The maximum drawdown for the PACB was -98.22%, occurring on May 27, 2025. This drawdown has not yet recovered.
The current PACB drawdown is -96.91%.
Since Oct 27, 2010 PACB has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 3 times
- 10% or more: 5 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -98.22% | Feb 11, 2021 | 1076 | May 27, 2025 | Ongoing | Ongoing | Ongoing |
| -93.52% | Oct 28, 2010 | 514 | Nov 13, 2012 | 2026 | Dec 1, 2020 | 2540 |
| -22.74% | Jan 19, 2021 | 6 | Jan 27, 2021 | 10 | Feb 10, 2021 | 16 |
| -11.19% | Dec 8, 2020 | 7 | Dec 17, 2020 | 2 | Dec 21, 2020 | 9 |
| -10.95% | Dec 23, 2020 | 3 | Dec 29, 2020 | 6 | Jan 7, 2021 | 9 |
| -9.44% | Jan 8, 2021 | 2 | Jan 12, 2021 | 2 | Jan 14, 2021 | 4 |
| -2.11% | Jan 14, 2021 | 1 | Jan 15, 2021 | 1 | Jan 19, 2021 | 2 |